SPONSOR
British Columbia Cancer Agency
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Oligometastatic Prostate CancerPancreatic CancerPDAC - Pancreatic Ductal AdenocarcinomaHyperglycemiaMetastatic CancersAdvanced CancersCancers That Cannot be Treated With Curative Intent
British Columbia Cancer Agency is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Oligometastatic Prostate Cancer, Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, Hyperglycemia.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — British Columbia Cancer Agency
How many clinical trials has British Columbia Cancer Agency sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by British Columbia Cancer Agency, of which 3 are actively recruiting participants. These trials cover conditions including Oligometastatic Prostate Cancer, Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does British Columbia Cancer Agency research focus on?
British Columbia Cancer Agency clinical trials span Oligometastatic Prostate Cancer, Pancreatic Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, Hyperglycemia, Metastatic Cancers, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a British Columbia Cancer Agency clinical trial?
To participate in a British Columbia Cancer Agency trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all British Columbia Cancer Agency trials with current recruitment status updated daily.
Clinical Trials by British Columbia Cancer Agency
NCT04610372
Recruiting
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
Oligometastatic Prostate Cancer
NCT05132244
Recruiting
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
Pancreatic Cancer
NCT02155621
Recruiting
Personalized Oncogenomics (POG) Program of British Columbia
Metastatic Cancers
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology